HBIO
Price
$2.10
Change
+$0.01 (+0.48%)
Updated
Dec 20, 04:59 PM (EDT)
73 days until earnings call
ICUI
Price
$156.88
Change
+$3.68 (+2.40%)
Updated
Dec 20, 04:59 PM (EDT)
71 days until earnings call
Ad is loading...

HBIO vs ICUI

Header iconHBIO vs ICUI Comparison
Open Charts HBIO vs ICUIBanner chart's image
Harvard Bioscience
Price$2.10
Change+$0.01 (+0.48%)
Volume$897
CapitalizationN/A
ICU Medical
Price$156.88
Change+$3.68 (+2.40%)
Volume$2.18K
CapitalizationN/A
HBIO vs ICUI Comparison Chart
Loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HBIO vs. ICUI commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIO is a Hold and ICUI is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (HBIO: $2.11 vs. ICUI: $156.82)
Brand notoriety: HBIO and ICUI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HBIO: 195% vs. ICUI: 339%
Market capitalization -- HBIO: $184.01M vs. ICUI: $2.55B
HBIO [@Medical Specialties] is valued at $184.01M. ICUI’s [@Medical Specialties] market capitalization is $2.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HBIO’s FA Score shows that 1 FA rating(s) are green whileICUI’s FA Score has 1 green FA rating(s).

  • HBIO’s FA Score: 1 green, 4 red.
  • ICUI’s FA Score: 1 green, 4 red.
According to our system of comparison, ICUI is a better buy in the long-term than HBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HBIO’s TA Score shows that 3 TA indicator(s) are bullish while ICUI’s TA Score has 5 bullish TA indicator(s).

  • HBIO’s TA Score: 3 bullish, 3 bearish.
  • ICUI’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ICUI is a better buy in the short-term than HBIO.

Price Growth

HBIO (@Medical Specialties) experienced а -2.31% price change this week, while ICUI (@Medical Specialties) price change was -2.98% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

HBIO is expected to report earnings on Mar 06, 2025.

ICUI is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICUI($2.55B) has a higher market cap than HBIO($184M). ICUI YTD gains are higher at: 57.229 vs. HBIO (-60.561). ICUI has higher annual earnings (EBITDA): 253M vs. HBIO (8.03M). ICUI has more cash in the bank: 255M vs. HBIO (4.28M). HBIO has less debt than ICUI: HBIO (42.8M) vs ICUI (1.7B). ICUI has higher revenues than HBIO: ICUI (2.26B) vs HBIO (112M).
HBIOICUIHBIO / ICUI
Capitalization184M2.55B7%
EBITDA8.03M253M3%
Gain YTD-60.56157.229-106%
P/E RatioN/A333.33-
Revenue112M2.26B5%
Total Cash4.28M255M2%
Total Debt42.8M1.7B3%
FUNDAMENTALS RATINGS
HBIO vs ICUI: Fundamental Ratings
HBIO
ICUI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9591
PRICE GROWTH RATING
1..100
8446
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICUI's Valuation (92) in the Medical Specialties industry is in the same range as HBIO (99) in the Biotechnology industry. This means that ICUI’s stock grew similarly to HBIO’s over the last 12 months.

ICUI's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as HBIO (100) in the Biotechnology industry. This means that ICUI’s stock grew similarly to HBIO’s over the last 12 months.

ICUI's SMR Rating (91) in the Medical Specialties industry is in the same range as HBIO (95) in the Biotechnology industry. This means that ICUI’s stock grew similarly to HBIO’s over the last 12 months.

ICUI's Price Growth Rating (46) in the Medical Specialties industry is somewhat better than the same rating for HBIO (84) in the Biotechnology industry. This means that ICUI’s stock grew somewhat faster than HBIO’s over the last 12 months.

ICUI's P/E Growth Rating (2) in the Medical Specialties industry is in the same range as HBIO (2) in the Biotechnology industry. This means that ICUI’s stock grew similarly to HBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HBIOICUI
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
70%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
65%
MACD
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
65%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 14 days ago
69%
Declines
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 4 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
67%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
66%
View a ticker or compare two or three
Ad is loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFDTX19.570.21
+1.08%
Hartford Schroders US MidCap Opps R5
CRMMX21.370.21
+0.99%
CRM Mid Cap Value Inv
MSSYX9.480.06
+0.64%
AMG Frontier Small Cap Growth Z
FBGRX230.680.98
+0.43%
Fidelity Blue Chip Growth
DFSPX12.42-0.01
-0.08%
DFA Intl Sustainability Core 1

HBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HBIO has been loosely correlated with CTKB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if HBIO jumps, then CTKB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HBIO
1D Price
Change %
HBIO100%
+0.48%
CTKB - HBIO
48%
Loosely correlated
+2.10%
CRL - HBIO
45%
Loosely correlated
+1.99%
XRAY - HBIO
45%
Loosely correlated
+1.25%
PACB - HBIO
42%
Loosely correlated
+2.07%
KIDS - HBIO
41%
Loosely correlated
-0.93%
More

ICUI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with AXGN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then AXGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICUI
1D Price
Change %
ICUI100%
+2.36%
AXGN - ICUI
46%
Loosely correlated
+5.32%
HBIO - ICUI
43%
Loosely correlated
+0.48%
VCYT - ICUI
43%
Loosely correlated
+4.66%
NEOG - ICUI
43%
Loosely correlated
+0.17%
CLPT - ICUI
43%
Loosely correlated
+6.04%
More